Bill Ackman

Bill Ackman

Last Update: 2014-10-07

Number of Stocks: 6
Number of New Stocks: 0

Total Value: $12,597 Mil
Q/Q Turnover: 38%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

This information is for Members Only.


Please Sign Up for FREE membership. If you have already signed up, please Log In

This information is for Members Only.


Please Sign Up for FREE membership. If you have already signed up, please Log In


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

Gm1
ReplyGm1 - 1 month ago
Dear Sirs / Madams,

I am so interested in Pershing Square, would you please advise me its performance and cost? Thank you.

GM
Samchell@yahoo
ReplySamchell@yahoo - 6 months ago
Some stocks are best evaluated by hands-on personal empiricism. After going into a Walgreen's store, it's manifestly clear where it ranks compared to CVS or Rite Aid. As for Ackman's attraction to Mondelez, perhaps he likes some of the company's snack items, and no doubt enough other consumers will share his taste to move the stock in a positive direction. But anyone looking for more something more dramatic would be better advised to take note of the population's compulsive consumption of Hershey products. (Twizzler's Twist 'n Pull Cherry Licorice is candy heroin.) Also, like Coke and Kleenex, Hershey's is a brand name that's synonymous with the product. (When's the last time your spouse asked you to go to Walgreen's to pick up a "Mondelez Bar"?) In short, investing is a game of guessing, supported by past predilections and indicators that "may" have a bearing on future results. But 50% of stock picking is playing hunches. Never ignore the intangibles as well as personal impressions--that's can't be charted or measured by most systems.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK